Designer Brands (DBI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Fiscal 2024 saw a return to positive comparable sales in Q4 after nine quarters of declines, despite a 2.1% decrease in net sales to $3.0 billion and a net loss of $10.5 million.
Leadership was refreshed with new presidents for DSW and Brands, a new CMO, and a new Head of Merchandising, driving strategic progress and operational improvements.
The company focused on brand portfolio optimization, cost reduction, and enhancing the omnichannel customer experience.
Macro uncertainty, especially tariffs, is expected to impact fiscal 2025, with continued focus on expense management and private label brand growth.
Voting matters and shareholder proposals
Shareholders will vote on the election of four Class III directors, ratification of Deloitte as independent auditor for fiscal 2025, and an advisory resolution on executive compensation.
The board recommends voting FOR all proposals.
Shareholders may also submit director nominations and proposals for the 2026 meeting, following specific advance notice requirements.
Board of directors and corporate governance
The board consists of eleven members divided into three classes, with over two-thirds independent and all committees composed entirely of independent directors.
Separate CEO and Executive Chairman roles are maintained; independent directors meet regularly without management.
Annual board and committee evaluations are conducted, and there are robust stock ownership guidelines and anti-hedging policies.
Four standing committees: Audit, Human Capital and Compensation, Nominating and Corporate Governance, and Technology.
Latest events from Designer Brands
- Sales rose 0.6% as Brand Portfolio drove margin gains and 2024 guidance was reaffirmed.DBI
Q1 202531 Jan 2026 - Athleisure and kids' growth drove comps, but sales and outlook declined amid macro pressures.DBI
Q2 202521 Jan 2026 - Net sales fell 1.2%, gross margin declined, but adjusted operating income rose 40%.DBI
Q3 202511 Jan 2026 - Q4 saw a return to positive comps and 2025 guidance targets sales and EPS growth.DBI
Q4 202526 Dec 2025 - Gross margin and EPS surged, but sales fell; guidance expects further contraction.DBI
Q3 202611 Dec 2025 - Definitive proxy materials filed for shareholder voting, no fee required.DBI
Proxy Filing1 Dec 2025 - Q1 2025 sales dropped 8% and net loss reached $17.4M as cost cuts and uncertainty persisted.DBI
Q1 202614 Nov 2025 - Net sales fell 4.2% and comps dropped 5% amid inflation, tariffs, and macroeconomic uncertainty.DBI
Q2 202611 Sep 2025